MNKTQ — Mallinckrodt Share Price
0.000.00%
Last trade - 00:00- $3.19m
- -$9.21m
- $1.91bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -47.19% | ||
| Return on Equity | -571.35% | ||
| Operating Margin | -99.98% | ||
Financial Summary
| Year End 30th Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 3,215.6 | 3,162.5 | 2,749.4 | 2,208.8 | 1,914.3 | n/a | n/a | -9.89% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Mallinckrodt plc develops, manufactures, markets, and distributes branded and generic specialty pharmaceutical products and therapies. The Company operates in two reportable segments: Specialty Brands and Specialty Generics. The Specialty Brands includes specialty pharmaceutical brands. The Specialty Generics includes niche specialty generic drugs and active pharmaceutical ingredients. Its Specialty Generics segment is focused on providing its customers with specialty generic drugs and active pharmaceutical ingredients (APIs). The Company focuses on various therapeutic areas, such as autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics, cultured skin substitutes and gastrointestinal products. Its product portfolio includes Acthar Gel, INOmax, Therakos photopheresis, StrataGraft, Terlivaz, and Amitiza.
Directors
- Angus Russell NEC (65)
- Mark Trudeau PRE (60)
- Bryan Reasons CFO (53)
- Ian Watkins CHO (58)
- Steven Romano EVP (61)
- Mark Casey EVP (57)
- Hugh O'Neill EVP (57)
- David Carlucci IND (65)
- J. Martin Carroll IND (71)
- Paul Carter IND (60)
- David Norton IND (69)
- Carlos Paya IND (62)
- JoAnn Reed IND (65)
- Anne Whitaker IND (54)
- Kneeland Youngblood IND (65)
- Last Annual
- December 30th, 2022
- Last Interim
- September 29th, 2023
- Incorporated
- January 9th, 2013
- Public Since
- January 1st, 1970
- No. of Employees
- 2,700
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 26,542,639
- Address
- College Business & Technology Park, DUBLIN
- Web
- https://www.mallinckrodt.com/
- Phone
- +353 18207940
- Contact
- Daniel Speciale
- Auditors
- Deloitte & Touche LLP
Upcoming Events for MNKTQ
Similar to MNKTQ
Acacia Diversified Holdings
Pink Sheets on Nasdaq
Acusphere
Pink Sheets on Nasdaq
Soul Biotechnology
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
FAQ
What is the Mallinckrodt share price?
As of Today at 06:13 UTC, shares in Mallinckrodt are trading at $0.12. This share price information is delayed by 15 minutes.
How has the Mallinckrodt share price performed this year?
Shares in Mallinckrodt last closed at $0.12 and the price had moved by -99% over the past 365 days. In terms of relative price strength the Mallinckrodt share price has underperformed the S&P500 Index by -99.1% over the past year.
What are the analyst and broker recommendations for Mallinckrodt?
There is no consensus recommendation for this security.
Find out moreWhat is the Mallinckrodt dividend yield?
Mallinckrodt does not currently pay a dividend.
Does Mallinckrodt pay a dividend?
Mallinckrodt does not currently pay a dividend.
When does Mallinckrodt next pay dividends?
Mallinckrodt does not currently pay a dividend.
How do I buy Mallinckrodt shares?
To buy shares in Mallinckrodt you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Mallinckrodt?
As of the previous close price of $0.12, shares in Mallinckrodt had a market capitalisation of $3.19m.
Where are Mallinckrodt shares listed?
Here are the trading details for Mallinckrodt:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: MNKTQ
What kind of share is Mallinckrodt?
Based on an overall assessment of its quality, value and momentum Mallinckrodt is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Mallinckrodt share price forecast for 2023?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Mallinckrodt share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mallinckrodt. Over the past six months, its share price has underperformed the S&P500 Index by -89.78%.
As of the last closing price of $0.12, shares in Mallinckrodt were trading -96.12% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Mallinckrodt PE Ratio?
The Mallinckrodt PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.12.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Mallinckrodt?
Mallinckrodt's management team is headed by:
- Angus Russell - NEC
- Mark Trudeau - PRE
- Bryan Reasons - CFO
- Ian Watkins - CHO
- Steven Romano - EVP
- Mark Casey - EVP
- Hugh O'Neill - EVP
- David Carlucci - IND
- J. Martin Carroll - IND
- Paul Carter - IND
- David Norton - IND
- Carlos Paya - IND
- JoAnn Reed - IND
- Anne Whitaker - IND
- Kneeland Youngblood - IND